Oragenics, Inc. is a biopharmaceutical company. The company is focused on developing novel antibiotics against infectious disease and treatments for oral mucositis. It also develops, markets, and sells proprietary probiotics designed to enhance oral health for humans and pets under Evora and ProBiora brand names. Oragenics was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.
